key: cord-0765518-o024asit
authors: Huang, Yan-Jang S.; Bilyeu, Ashley N.; Hsu, Wei-Wen; Hettenbach, Susan M.; Willix, Joshua L.; Stewart, Savannah C.; Higgs, Stephen; Vanlandingham, Dana L.
title: Treatment with Dry Hydrogen Peroxide Accelerates the Decay of Severe Acute Syndrome Coronavirus-2 on Non-porous Hard Surfaces
date: 2021-07-15
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2021.07.006
sha: 7186d1fa9079992d233a03ef193d4677d572289f
doc_id: 765518
cord_uid: o024asit

BACKGROUND: Disinfection of contaminated or potentially contaminated surfaces has become an integral part of the mitigation strategies for controlling coronavirus disease 2019. Whilst a broad range of disinfectants are effective in inactivating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), application of disinfectants has a low throughput in areas that receive treatments. Disinfection of large surface areas often involves the use of reactive microbiocidal materials, including ultraviolet germicidal irradiation, chlorine dioxide, and hydrogen peroxide vapor. Albeit these methods are highly effective in inactivating SARS-CoV-2, the deployment of these approaches creates unacceptable health hazards and precludes the treatment of occupied indoor spaces using existing disinfection technologies. In this study, the feasibility of using dry hydrogen peroxide (DHP) in inactivating SARS-CoV-2 on contaminated surfaces in large indoor spaces was evaluated. METHODS: Glass slides were inoculated with SARS-CoV-2 and treated with DHP between 5 and 25 ppb for up to 24 hours. Residual infectious virus samples were eluted from three replicates at each time point and titrated in African green monkey VeroE6 cells. RESULTS: In comparison with the observed relatively high stability of SARS-CoV-2 on contaminated glass slides (control group), residual infectious titers of glass slides inoculated with SARS-CoV-2 were significantly reduced after receiving 120 minutes of DHP treatment. CONCLUSIONS: The accelerated decay of SARS-CoV-2 on contaminated glass slides suggests that treatment with DHP can be an effective surface disinfection method for occupied indoor spaces.

 Severe acute respiratory coronavirus-2 (SARS-CoV-2) is sensitive to dry hydrogen peroxide (DHP) treatment.

 Release of DHP between 5 and 25 ppb is effective in inactivating SARS-CoV-2 present on contaminated glass slides.

 A contact time of 120 minutes or greater is required for DHP treatment to have demonstrable impact on the residue infectivity of SARS-CoV-2 on contaminated glass slides.

to unprecedented disease burden and economic losses worldwide. In addition to the exposure to respiratory droplets from infected individuals, contaminated environments have also been suggested to play a role in the spread of SARS-CoV-2 1,2 . Whilst direct evidence supporting the transmission through contact with a contaminated environment may be hard to establish, this perception is further strengthened by the high environmental stability survival of SARS-CoV-2 and two related coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS) 3, 4 . Therefore, routine cleaning and disinfection of surfaces to inactivate residual viruses has been recommended for households and public spaces.

A range of chemical disinfectants can be used to inactivate SARS-CoV-2 on contaminated surfaces 5 . Manual application of disinfectants has a limited range in the area of surface disinfection. Treatment of large complex surfaces often requires specialized equipment that is operated by highly trained individuals and often involves hazardous materials. Ultraviolet germicidal irradiation (UVGI) is the most commonly used method for environmental disinfection. UV-C at wavelengths between 100 nm and 280 nm have been proven to be effective against SARS-CoV-2 6 . However, factors such as distances from the sources of UV-C, dust, and environmental pollutants can limit the germicidal potency 7 . Several chemical disinfectants such as hydrogen peroxide and chlorine dioxide can be vaporized and used to disinfect indoor spaces 8 . Existing environmental disinfection methods often create health hazards during the pathogen inactivation process. With the exception of retrofitting UV-C modules in air filtration systems 9 , the deployment of environmental disinfection equipment to inactivate SARS-CoV-2 in occupied indoor spaces remains impractical.

In this study, we demonstrated the feasibility of inactivating SARS-CoV-2 on dried contaminated surfaces present in large indoor spaces using dry hydrogen peroxide (DHP). In contrast to the health hazards created by the fumigation of indoor spaces with hydrogen peroxide, the release of DHP has been proven to be safe for humans and previously evaluated for the inactivation of bacterial pathogens in healthcare facilities 10, 11 . Reduced infectious titers of SARS-CoV-2 recovered from contaminated surfaces after the release of DHP in a 50 m 2 laboratory suggest the potential use of DHP for the environmental disinfection during the ongoing COVID pandemic may be useful.

of virus stocks and samples were performed using VeroE6 cells 12 . All cultures were maintained in high-glucose Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 10% tryptose phosphate broth, penicillin (100 unit/ml), streptomycin (100 µg/ml), and L-glutamine (2 mM). SARS-CoV-2 USA-WA-1/2020 was originally acquired from BEI Resources (Lot number 70033175) and passaged twice to generate the stocks used in this study. Infectious titers of all samples were quantified using median tissue culture infectious dose (TCID 50 ) method as previously described 13 .

Dried contaminated surfaces were created using 25 mm (W) x 75 mm (L) x 1 mm (D) microscope glass slides spiked with SARS-CoV-2. Standard glass microscope slides were selected for testing based on the published report on the recovery of infectious viruses up to 48 hours after the inoculation of SARS-CoV-2 and desiccation 14 .

Contaminated glass slides were used to determine the decay of residual infectious titers after the initiation of DHP treatment and compared to slides in the control group, which did not receive DHP treatment.

Each glass slide was spiked with 250 μl of SARS-CoV-2 stocks at approximately 6 log 10 TCID 50 /ml followed by drying inside a class II A2 biosafety cabinet for one hour.

Three contaminated glass slides were randomly assigned as a set, placed inside a 100 mm x 100 mm square petri dishes, sealed with parafilm and transported to two biosafety level-3 large animal (BSL-3Ag) laboratories that are each 50 m 2 in size. The first laboratory was charged with DHP by allowing the continuous operation of a Sentry DHP generator at full output of 38 cubic feet per minute (Synexis LLC, Lenexa, KS) for 24 hours prior to the experiment. This setting generates DHP at a concentration no greater than 25 parts per billion (ppb) 15 .The second laboratory was used as a control environment which maintained the negative air pressure required for BSL-3 laboratories.

To simulate the air exchange conditions in public spaces, the rate of air exchange in both BSL-3Ag laboratories was reduced to seven air exchanges per hour, the minimal frequency required for the maintenance of negative air pressure. Ambient temperature was maintained at 22°C throughout the experiment. Relative humidity was set at 55% It is known that residual titers of SARS-CoV-2 on contaminated surfaces incubated at ambient atmosphere can be detected up to 28 days after inoculation 17 . In this study, the continuous DHP treatment for 24 hours led to the inactivation of SARS-CoV-2. Quantities of infectious viruses recovered from glass slides exposed to DHP (1.1 log 10 TCID 50 /ml) were significantly lower than those without treatment (3.5 log 10 TCID 50 /ml) at this given timepoint (p<0.0001). It is also noteworthy that 33.3% (1/3) of DHP treated samples did not contain detectable viruses at both 240 and 140 minutes after the initiation of treatment.

Collectively, SARS-CoV-2 present on contaminated glass slides is sensitive to the treatment of DHP deployed at a sufficiently high concentration. In our study, DHP at 5-25 ppb requires a contact time of 120 minutes to inactivate approximately 98.7% of residual infectious viruses from the initial inoculum containing approximately 3.6 log 10 TCID 50 /ml of infectious viruses. In conclusion, our work demonstrates the feasibility of using DHP in reducing the risk of SARS-CoV-2 transmission in occupied indoor spaces.

and gives rise to half-lives of approximately six days on glass and other non-porous surfaces 17 . DHP treatment evaluated in this study led to the accelerated decay of SARS-CoV-2 on contaminated glass slides. Continuous DHP treatment for 120 minutes was required for demonstrable reduction of residual infectious titers. Complete inactivation of SARS-CoV-2 up to 3.6 log 10 TCID 50 /ml is likely to require treatments for 240 minutes or longer as observed in this study. The results showed that DHP provides an effective solution for the need of decontaminating occupied indoor spaces during the COVID-19 pandemic. Because the stability of SARS-CoV-2 on contaminated glass is indistinguishable with other non-porous surfaces tested in published studies 16,17 , our results provide the basis for evaluating the feasibility of using DHP to inactivate residual infectious viruses on other materials, including plastic, stainless steel, and vinyl.

Our data are consistent with the previous reports that coronaviruses are relatively environmentally stable but are sensitive to vaporized hydrogen peroxide 8 . Dry fogging of hydrogen peroxide in the form of mixtures containing peroxyacetic acid and hydrogen peroxide has also been demonstrated to be effective in inactivating SARS-CoV-2 18 . In this study, the use of a commercially available portable device can provide a standardized and simplified decontamination procedure for contaminated surfaces containing SARS-CoV-2. The inactivation was achieved using a lower concentration at 5-25 ppb, which is approximately 40 times lower than the concentration of hydrogen peroxide produced using commercially available generators 8 . Although the lower concentration requires a longer contact time, it enables continuous decontamination of occupied indoor spaces. This approach provides an alternative for facilities that are incompatible with the retrofitting of air handling units with UVGI systems in order to decontaminate large surface areas. DHP treatment is also comparable with copper coating technologies developed to inactivate SARS-CoV-2 on non-porous surfaces 19, 20 .

The deployment of DHP in surface decontamination provides an advantage over copper coating technologies, which require specific instrument or solvent used to promote attachment of copper or copper oxide to different surfaces.

Our study provides the first evidence for the virucidal activity of DHP, which has mainly been validated for the inactivation of human bacterial pathogens in the past 15 

The role of the healthcare surface environment in SARS-CoV-2 transmission and potential control measures

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination

Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions

Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. medRxiv

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces

Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation

Effectiveness of an ultraviolet-C disinfection system for reduction of healthcare-associated pathogens

Evaluating the virucidal efficacy of hydrogen peroxide vapour

Impact of UVC-sustained recirculating air filtration on airborne bacteria and dust in a pig facility

Environmental meticillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide

Disinfecting noncritical medical equipment-Effectiveness of hydrogen peroxide dry mist as an adjunctive method

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge

Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h

Effectiveness of dry hydrogen peroxide on reducing environmental microbial bioburden risk in a pediatric oncology intensive care unit

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

The effect of temperature on persistence of SARS-CoV-2 on common surfaces

Airborne disinfection by dry fogging efficiently inactivates SARS-CoV-2, mycobacteria and bacterial spores and shows the limits of commercial spore carriers for process control

Sars-CoV-2 (COVID-19) inactivation capability of coppercoated touch surface fabricated by cold-spray technology

A Surface Coating that Rapidly Inactivates SARS-CoV-2

The study was performed in the biosafety level-3 and large animal biosafety level-3 laboratories at the Biosecurity Research Institute (BRI), Kansas State University. The authors would like to thank the technical assistance provided by Mr. John R. Henneman, Mr. Eric L. Montgomery, and the research support staff at the BRI. This study was supported by Synexis LLC. The sponsor had no role in study design, experimental procedures, or data analysis.